Advanced search
Publication Cover
Journal of Asthma Volume 61, 2024 - Issue 4
Submit an article Journal homepage
958
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Comparison of extrafine beclomethasone dipropionate/formoterol fumarate dry powder inhaler and pressurized metered-dose inhaler in Chinese patients with asthma: the FORTUNE study

Jinping Zhenga State Key Lab of Respiratory Disease, National Clinical Research Center of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaView further author information
, MD,
Jianyong Zhangb Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaView further author information
, MD,
Xiuhua Fuc Respiratory Department, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, ChinaView further author information
, MD,
Changqing Lind Department of Respiratory Medicine, Huizhou Central People’s Hospital, Huizhou, ChinaView further author information
, MD,
Xinri Zhange NHC Key Laboratory of Pneumoconiosis, Shanxi Key Laboratory of Respiratory Diseases, The First Hospital of Shanxi Medical University, Taiyuan, ChinaView further author information
, MD,
Xiaodong Meif Department of Respiratory and Critical Care Medicine, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, ChinaView further author information
, MD,
Massimo Corradig Department of Medicine and Surgery, University of Parma, Parma, ItalyView further author information
, MD,
Glauco Cappellinih Global Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyView further author information
, MSc,
Emanuele Calabroh Global Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyView further author information
, MSc,
Cissy Zhui Global Clinical Development, Chiesi Pharmaceutical Consulting (Shanghai) Co. Ltd, Shanghai, ChinaView further author information
, BSc, BA &
Eva Topoleh Global Clinical Development, Chiesi Farmaceutici SpA, Parma, ItalyCorrespondence[email protected]
View further author information
, MD show all
Pages 360-367 | Received 28 Jul 2023, Accepted 15 Oct 2023, Published online: 01 Nov 2023

References

  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention [Internet]. Available from: https://ginasthma.org/gina-reports/ [2022; last accessed 11 January 2023].
  • Vanoverschelde A, Van Der Wel P, Putman B, Lahousse L. Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies. BMJ Open Respir Res. 2021;8(1):e000823. doi:10.1136/bmjresp-2020-000823.
  • Van Beerendonk I, Mesters I, Mudde AN, Tan TD. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma. 1998;35(3):273–279. doi:10.3109/02770909809068218.
  • Ding B, Small M, Scheffel G, Holmgren U. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma–COPD overlap syndrome consulting for routine care. Int J Chron Obstruct Pulmon Dis. 2018;13:927–936. doi:10.2147/COPD.S154525.
  • Corradi M, Chrystyn H, Cosio BG, Pirozynski M, Loukides S, Louis R, Spinola M, Usmani OS. NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthma. Expert Opin Drug Deliv. 2014;11(9):1497–1506. doi:10.1517/17425247.2014.928282.
  • Muralidharan P, Hayes D, Mansour HM. Dry powder inhalers in COPD, lung inflammation and pulmonary infections. Expert Opin Drug Deliv. 2015;12(6):947–962. doi:10.1517/17425247.2015.977783.
  • Kanniess F, Scuri M, Vezzoli S, Francisco C, Petruzzelli S. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler®) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: a randomised, double-blind trial. Pulm Pharmacol Ther. 2015;30:121–127. doi:10.1016/j.pupt.2014.07.006.
  • Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J. 1999;14(1):23–27. doi:10.1034/j.1399-3003.1999.14a06.x.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.